Please use this identifier to cite or link to this item: https://ri.ufs.br/jspui/handle/riufs/24168
Document Type: Artigo
Title: Amyotrophic lateral sclerosis: a focus on disease progression
Authors: Calvo, Ana Cristina
Manzano, Raquel
Mendonça, Deise Maria Furtado de
Muñoz, María J.
Zaragoza, Pilar
Osta, Rosario
Issue Date: Aug-2014
Resumo : Since amyotrophic lateral sclerosis (ALS) was discovered and described in 1869 as a neurodegenerative disease in which motorneuron death is induced, a wide range of biomarkers have been selected to identify therapeutic targets. ALS shares altered molecular pathways with other neurodegenerative diseases, such as Alzheimer’s, Huntington’s, and Parkinson’s diseases. However,the molecular targets that directly influence its aggressive nature remain unknown. What is the first link in the neurodegenerativechain of ALS that makes this disease so peculiar? In this review, we will discuss the progression of the disease from the viewpointof the potential biomarkers described to date in human and animal model samples. Finally, we will consider potential therapeuticstrategies for ALS treatment and future, innovative perspectives.
Keywords: Amyotrophic lateral sclerosis
Neurodegenerative diseases
Disease progression
Therapeutic strategies
ISSN: 2314-6141
Is part of: BioMed Research International
Language: eng
Publisher / Institution : Hindawi Publishing Corporation
Citation: CALVO, A. C. et al. Amyotrophic lateral sclerosis: a focus on disease progression. BioMed Research International, v. 2014, ago. 2014. Disponível em: https://onlinelibrary.wiley.com/doi/epdf/10.1155/2014/925101. Acesso em: 9 jan. 2026.
License: Creative Commons Atribuição 3.0 Não Adaptada (CC BY 3.0)
URI: https://ri.ufs.br/jspui/handle/riufs/24168
Appears in Collections:DBCI - Artigos de periódicos

Files in This Item:
File Description SizeFormat 
AmyotrophicLateralSclerosisDiseaseProgression.pdf376,06 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.